UP-818-CC Injection in Healthy Chinese Subjects

NCT07355621 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: UP-818-CC injection
OTHER: Placebo

Sponsor

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.